Log in

NYSE:SNYSanofi Stock Price, Forecast & News

$49.11
+0.43 (+0.88 %)
(As of 05/29/2020 04:00 PM ET)
Add
Compare
Today's Range
$48.25
Now: $49.11
$49.48
50-Day Range
$44.38
MA: $47.60
$50.63
52-Week Range
$37.62
Now: $49.11
$51.84
Volume1.67 million shs
Average Volume2.32 million shs
Market Capitalization$122.98 billion
P/E Ratio15.69
Dividend Yield2.40%
Beta0.67
Sanofi provides therapeutic solutions. It offers Cerezyme and Cerdelga for Gaucher disease, Myozyme and Lumizyme for Pompe disease, Fabrazyme for Fabry disease, and Aldurazyme for mucopolysaccharidosis Type 1; Aubagio, an immunomodulatory; and Lemtrada, a monoclonal antibody to treat multiple sclerosis. The company also provides Jevtana, a taxane derivative for prostate cancer; Taxotere, a taxoid for cancers; Eloxatin, an agent for colorectal cancer; Thymoglobulin, an immunosuppressive and immunomodulating agent; Mozobil, a hematopoietic stem cell mobilizer; and Zaltrap, a protein for metastatic colorectal cancer. In addition, it offers Dupixent for atopic dermatitis; Kevzara for rheumatoid arthritis; Lantus, Toujeo, Apidra, and Insuman insulins; Amaryl, an oral sulfonylurea; Lyxumia/Adlyxin, a GLP-1 receptor agonist; Soliqua 100/33/Suliqua, an insulin glargine and lixisenatide combination to treat diabetes; Admelog/Insulin lispro insulin; Praluent, a cholesterol-lowering drug; and Multaq, an anti-arrhythmic drug for atrial fibrillation. Further, the company provides Plavix, an anti-platelet agent for atherothrombotic conditions; Lovenox, a heparin for the prophylaxis and venous thromboembolism and acute coronary syndrome; Aprovel and CoAprovel anti-hypertensives; Renagel and Renvela oral phosphate binders for patients undergoing dialysis; Synvisc and Synvisc-One viscosupplements for osteoarthritis; Stilnox for insomnia; and Allegra for seasonal allergic rhinitis and uncomplicated hives. Additionally, it offers consumer health care products and generic medicines; and pediatric, influenza, adult and adolescent booster, meningitis, and travel and endemic vaccines. Sanofi has strategic alliance with Sensile Medical Ltd.; collaboration with Evotec AG; and partnership with REVOLUTION Medicines, Inc. The company was formerly known as Sanofi-Aventis and changed its name to Sanofi in May 2011. Sanofi was founded in 1973 and is headquartered in Paris, France.
Read More
Sanofi logo

Beat the Market (BTM) Rank

Analyst Opinion: 2.3Community Rank: 2.3Dividend Strength: 3.3Insider Behavior: 0.0Valuation: 1.3 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

1.84 out of 5 stars


Industry, Sector and Symbol

Industry Pharmaceutical preparations
Sub-IndustryN/A
SectorMedical
CUSIPN/A
Phone33-1-53-77-44-00

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$39.60 billion
Cash Flow$5.40 per share
Book Value$26.11 per share

Profitability

Net Income$4.28 billion

Miscellaneous

EmployeesN/A
Outstanding Shares2,504,138,000
Market Cap$122.98 billion
Next Earnings Date8/3/2020 (Estimated)
OptionableOptionable

Receive SNY News and Ratings via Email

Sign-up to receive the latest news and ratings for SNY and its competitors with MarketBeat's FREE daily newsletter.

Sanofi (NYSE:SNY) Frequently Asked Questions

How has Sanofi's stock been impacted by COVID-19 (Coronavirus)?

Sanofi's stock was trading at $44.79 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization (WHO). Since then, SNY stock has increased by 9.6% and is now trading at $49.11. View which stocks have been most impacted by Coronavirus.

Do Wall Street analysts recommend investors buy shares of Sanofi?

12 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Sanofi in the last year. There are currently 4 hold ratings and 8 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View analyst ratings for Sanofi.

When is Sanofi's next earnings date?

Sanofi is scheduled to release its next quarterly earnings announcement on Monday, August 3rd 2020. View our earnings forecast for Sanofi.

How were Sanofi's earnings last quarter?

Sanofi SA (NYSE:SNY) issued its quarterly earnings results on Wednesday, October, 31st. The company reported $1.07 earnings per share for the quarter, beating the Zacks' consensus estimate of $0.98 by $0.09. The business had revenue of $9.39 billion for the quarter, compared to the consensus estimate of $9.10 billion. Sanofi had a net margin of 12.20% and a return on equity of 18.18%. The firm's revenue was up 1.5% compared to the same quarter last year. During the same period last year, the company posted $1.71 earnings per share. View Sanofi's earnings history.

What guidance has Sanofi issued on next quarter's earnings?

Sanofi issued an update on its FY 2020 Pre-Market earnings guidance on Friday, April, 24th. The company provided earnings per share (EPS) guidance of 6.81-6.87 for the period.

What price target have analysts set for SNY?

12 brokerages have issued twelve-month price objectives for Sanofi's shares. Their forecasts range from $52.00 to $58.00. On average, they anticipate Sanofi's stock price to reach $55.33 in the next year. This suggests a possible upside of 12.7% from the stock's current price. View analysts' price targets for Sanofi.

Has Sanofi been receiving favorable news coverage?

Media stories about SNY stock have trended negative recently, InfoTrie Sentiment Analysis reports. The research firm identifies negative and positive news coverage by reviewing more than six thousand blog and news sources in real time. The firm ranks coverage of companies on a scale of -5 to 5, with scores nearest to five being the most favorable. Sanofi earned a news sentiment score of -2.5 on InfoTrie's scale. They also gave media stories about the company a news buzz of 0.0 out of 10, meaning that recent news coverage is extremely unlikely to have an effect on the stock's share price in the immediate future. View the latest news aboutSanofi.

Who are some of Sanofi's key competitors?

What other stocks do shareholders of Sanofi own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Sanofi investors own include Gilead Sciences (GILD), Johnson & Johnson (JNJ), Pfizer (PFE), Cisco Systems (CSCO), Walt Disney (DIS), Alibaba Group (BABA), Intel (INTC), AbbVie (ABBV), AT&T (T) and Merck & Co., Inc. (MRK).

Who are Sanofi's key executives?

Sanofi's management team includes the following people:
  • Mr. Olivier Brandicourt, CEO & Director (Age 62)
  • Mr. Jean-Baptiste Chasseloup de Chatillon, Exec. VP & CFO (Age 53)
  • Mr. Laurent Gilhodes, Principal Accounting Officer and VP of Corp. Accounting
  • Mr. Bruno Ménard, Chief Information officer
  • Mr. George Grofik, Head of Investor Relations

What is Sanofi's stock symbol?

Sanofi trades on the New York Stock Exchange (NYSE) under the ticker symbol "SNY."

Who are Sanofi's major shareholders?

Sanofi's stock is owned by a variety of institutional and retail investors. Top institutional investors include Fisher Asset Management LLC (0.71%), BlackRock Inc. (0.53%), Invesco Ltd. (0.29%), Morgan Stanley (0.21%), Morgan Stanley (0.21%) and Parametric Portfolio Associates LLC (0.10%). View institutional ownership trends for Sanofi.

Which institutional investors are selling Sanofi stock?

SNY stock was sold by a variety of institutional investors in the last quarter, including Nuveen Asset Management LLC, Invesco Ltd., Sphera Funds Management LTD., 1832 Asset Management L.P., HighTower Advisors LLC, Guardian Capital LP, Grantham Mayo Van Otterloo & Co. LLC, and St. James Investment Company LLC. View insider buying and selling activity for Sanofi.

Which institutional investors are buying Sanofi stock?

SNY stock was purchased by a variety of institutional investors in the last quarter, including BlackRock Inc., JPMorgan Chase & Co., Cambiar Investors LLC, Morgan Stanley, Morgan Stanley, Cookson Peirce & Co. Inc., Citigroup Inc., and Eaton Vance Management. View insider buying and selling activity for Sanofi.

How do I buy shares of Sanofi?

Shares of SNY can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is Sanofi's stock price today?

One share of SNY stock can currently be purchased for approximately $49.11.

How big of a company is Sanofi?

Sanofi has a market capitalization of $122.98 billion and generates $39.60 billion in revenue each year. The company earns $4.28 billion in net income (profit) each year or $3.13 on an earnings per share basis.

What is Sanofi's official website?

The official website for Sanofi is www.sanofi.com.

How can I contact Sanofi?

Sanofi's mailing address is 54 RUE LA BOETIE, PARIS I0, 75008. The company can be reached via phone at 33-1-53-77-44-00 or via email at [email protected]

This page was last updated on 6/1/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.